More articles from Lung Cancer

IL-17A promotes tumorigenesis and upregulate PD-L1 expression in Non-small cell lung cancer
Hua Liao, Hangming Dong

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2204; DOI: 10.1183/13993003.congress-2023.PA2204
Association of DNA repair gene O6-Methylguanine-DNA Methyltransferase (MGMT) expression with aberrant promoter methylation in Lung Cancer Progression
Supriya Karpathak, Rajiv Garg, Mohammad Kaleem Ahmad, Anand Srivastava, Neelam Misra, Anurag Kumar Srivastav

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2208; DOI: 10.1183/13993003.congress-2023.PA2208
Late Breaking Abstract - Factors affecting recurrence in early stage lung adenocarcinoma
Fatma Canbay, Ayperi Merzi Öztürk, Sema Canbakan, Funda Demirağ, Hakan Ertürk

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2203; DOI: 10.1183/13993003.congress-2023.PA2203
Evaluation of PD-1 T lymphocytes in bronchoalveolar lavage in lung cancer compared to benign lung diseases
Barbara Hammer, Christina Bal, Maximilian Gysan, Sonja Zehetmayer, Silvana Geleff, Andreas Zech, Markus Kramer, Seda Ayazseven, Marco Idzko, Mir Alireza Hoda, Daniela Gompelmann

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2212; DOI: 10.1183/13993003.congress-2023.PA2212
Identification of predictive factors for early relapse in patients with unresectable stage Ⅲ NSCLC receiving consolidation durvalumab after concurrent chemoradiation therapy
Jung Hyun Nam, Chang Dong Yeo, Chan Kwon Park, Sung Kyoung Kim, Ju Sang Kim, Yong Hyun Kim, Jin Woo Kim, Seung Joon Kim, Sang Haak Lee, Hye Seon Kang

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1698; DOI: 10.1183/13993003.congress-2023.PA1698
Exploration of anticancer drug response prediction model using patient derived organoids with ALK-positive lung cancer
Hyeong Jun Cho, Sang-Yun Lee, Dong Woo Lee, Seung Joon Kim, Chang Dong Yeo

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1706; DOI: 10.1183/13993003.congress-2023.PA1706
Quantitative analysis of preoperative, intraoperative and postoperative circulating cell-free DNA in patients with resectable non-small cell lung cancer
Stylianos Gaitanakis, Anna Papadopoulou, Eleni Kokkotou, Timothy Sakellaridis, Periklis Tomos, Lamprini Stournara, Maria Mani, Eleutheria Ntalakou, Andriani Charpidou, Dimitra Grapsa

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1699; DOI: 10.1183/13993003.congress-2023.PA1699
Comparing the Effectiveness of Different Anti-angiogenetic Agents Combined with an EGFR-TKI in Metastatic Lung Adenocarcinoma
Chung-Wen Huang, Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, Inn-Wen Chong

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1714; DOI: 10.1183/13993003.congress-2023.PA1714
Study of the efficacy of intravenous BCG in a metastatic lung adenocarcinoma mouse model.
Claudia Guerrero, Eduardo Moreo, Santiago Uranga, Ana Belen Gomez, Carlos Martín, Nacho Aguiló

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1713; DOI: 10.1183/13993003.congress-2023.PA1713
Prognostic implication of KRAS G12C mutation in a real-world KRAS mutated stage IV NSCLC cohort treated with immunotherapy in the Netherlands
Anneloes L. Noordhof, Esther M. Swart, Ronald A.M. Damhuis, Lizza E.L. Hendriks, Peter W.A. Kunst, Mieke J. Aarts, Wouter H. Van Geffen

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1705; DOI: 10.1183/13993003.congress-2023.PA1705

Main menu

User menu

Search

More articles from Lung Cancer

Pages

Contact us